Amanta Healthcare IPO Allotment Status Out: How to Check, Final Subscription, GMP, and Listing Timeline

The basis of allotment for the Amanta Healthcare IPO has been finalised today after a strong three-day subscription window. Investors can now check their status on the registrar and exchange portals and prepare for demat credit and listing next week. Here’s a simple, step‑by‑step guide with key numbers and dates to make the next steps easy.

Quick IPO Snapshot

Issue size: ₹126 crore, 100% fresh issue of 1 crore shares
Price band: ₹120–₹126 per share
Lot size: 119 shares; minimum retail investment ₹14,994 at the upper band
Issue window: September 1–3, 2025
Registrar: MUFG Intime India; Lead manager: Beeline Capital Advisors
Business: Sterile liquid pharmaceuticals (parenteral solutions) with new manufacturing line capex planned via IPO proceeds

Final Subscription Numbers

The IPO was subscribed an overall 82.60–82.61 times, with category-wise traction as follows:

QIB: 35.86x
NII: 209.40–209.42x
Retail: 54.96–54.98x
This reflects very strong HNI and solid retail demand, alongside robust institutional interest.

How to Check Allotment Status

Keep PAN, Application Number, or DP Client ID handy.

Registrar (MUFG Intime India)

Go to the MUFG Intime India allotment portal.
Select “Amanta Healthcare.”
Enter PAN/Application No./DP Client ID and submit to view status.

Visit BSE Investor Services > Status of Issue Application.
Issue Type: Equity; Issue Name: Amanta Healthcare.
Enter PAN/Application No., complete captcha, and search.

Use NSE’s IPO bid verification module.
Enter PAN and Application No. to fetch the status.

Bank/UPI tip: If allotted, the mandate remains debited; if not, the mandate will be released and funds unblocked automatically after finalisation.

Post‑Allotment Timeline

Allotment finalisation: September 4, 2025 (today)
Refunds/mandate unblocking: On or about September 5 or September 8, 2025 (as per outlets)
Shares credited to demat: On or about September 8, 2025
Listing date: Monday, September 8 or Tuesday, September 9, 2025 (exchanges indicate Sep 9)

Note: Minor date differences appear across outlets; rely on the registrar/broker notification for exact processing and listing day.

GMP and Listing Preview

Grey market premium (GMP) indications hovered around ₹8.5–₹10 over the upper band near allotment day, implying a mid‑single‑digit listing pop if sentiment holds. GMP is unofficial and can change quickly with market conditions; use it only as a rough sentiment gauge.

What Drove Demand

Clear use of proceeds toward sterile injectable capacity (SteriPort/SVP lines) at the Hariyala, Kheda facility in Gujarat.
Pharma defensiveness and demand visibility for parenteral solutions.
Manageable issue size with strong participation across categories.

What Investors Should Do Now

Check allotment on MUFG Intime/BSE/NSE and verify demat credit before listing.
If allotted, set a plan for listing day based on risk tolerance and desired holding period; initial sessions can be volatile.
If not allotted, expect mandate release and consider staged secondary entries post‑listing instead of chasing the opening tick.

Bottom line: Amanta Healthcare’s allotment is out after a heavily oversubscribed issue. Track refunds/demat credit timelines and approach listing with a clear plan, factoring in fundamentals, valuation comfort, and current market tone.